47 results

• Large Doses of Antipsychotics May Increase Tardive Dyskinesia Risks: Study

  February 11, 2025

  Martha Garcia

  A new study links high doses of first-generation antipsychotics, like Thorazine, to an increased risk of patients developing involuntary muscle movements known as tardive dyskinesia.

• Reglan, Nortrip Side Effects Linked To Increased Stroke Risk: Study

  March 31, 2022

  Martha Garcia

  A new study links Reglan and similar anti-nausea drugs to an increased stroke risk, particularly when just starting treatment.

• Reglan Settlement Reportedly Reached for Tardive Dyskinesia Lawsuits

  February 1, 2017

  Irvin Jackson

  A tentative settlement could resolve thousands of Reglan tardive dyskinesia lawsuits nationwide.

• Generic Reglan Lawsuit Over Tardive Dyskinesia Warnings to Move Forward: NJ Court

  November 13, 2014

  Irvin Jackson

  A new Jersey appeals court has cleared the way for some generic Reglan lawsuits over claims of involuntary muscle movement, saying the cases are not preempted by federal law because some generic manufacturers delayed updating warning labels.

• Brand Name Drug Makers Liable For Generic Labels: Alabama Court

  August 22, 2014

  Irvin Jackson

  The Alabama Supreme Court has upheld a ruling holding brand name drug makers liable for the accuracy of label warnings on generic versions of their products.

• Study Finds No Link Between Reglan And Birth Defects

  October 17, 2013

  Irvin Jackson

  The anti-nausea drug Reglan shows no link to birth defects, according to a new study.

• Hospira Issues Lidocaine Injection Recall Due to Dark Particulate Matter

  October 7, 2013

  Russell Maas

  Hospira is recalling one lot of lidocaine injection because it could be contaminated with steel particles.

• Generic Reglan and Zofran Recall By Hospira Due to Glass Particles

  October 3, 2013

  Irvin Jackson

  Hospira has announced a generic Reglan and generic Zofran recall due to potential glass contamination.

• Neurological Side Effects of Reglan Lead to Restrictions in Europe

  July 31, 2013

  Irvin Jackson

  Generic Reglan faces new restrictions in Europe due to concerns over tardive dyskinesia movement disorder risks.

• Innovator Liability Ruling to be Reconsidered by Alabama Supreme Court

  June 18, 2013

  Irvin Jackson

  The Alabama Supreme Court will allow a rehearing on a ruling that would hold brand name manufacturers liable for the labels of generic versions of their drug.